EGFL8 and gastric cancer: In fact, our subsequent studies did indicate that the expression of EGFL8 was significantly decreased in colorectal and gastric cancer tissues and this decrease correlated significantly to the progression and prognosis of these two malignancies [14, 15], suggesting EGFL8 as a novel biomarker for gastroenterological cancers.